At CEO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Illinois based CEO’ operating in the Medical space. If you think a CEO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Co-Founder, Chairman and CEO of Verano Holdings
George Archos is the founder & CEO of Verano Holdings. He is a logistics and operations guru. Building on his extensive experience in coordinating complex freight delivery operations, as well as designing and operating highly-successful restaurants, George entered the cannabis industry in 2014 when he founded Ataraxia Grow and Labs in Illinois and was the first to receive authorization to grow medical cannabis out of 21 recipients of the coveted medical licenses. George’s diligence, perseverance, and tireless work ethic have made him one of the cannabis industry’s most successful entrepreneurs. Leveraging his unparalleled devotion to quality and a unique results-oriented approach to the cannabis industry, George has overseen the development of some of cannabis’s most highly-coveted operations and brands. George’s restaurants across the Chicagoland area, including Wildberry Pancakes & Café, Westwood Tavern & Tap and the Scout Waterhouse & Kitchen, all bear the imprint of his relentless devotion to quality and unrivaled customer service, earning him multiple awards and recognition. George’s unique experience, his admirable drive, and his unrelenting commitment to quality, coupled with his capacity to establish, build, and effectively run multi-jurisdictional companies, are an asset to Verano Holdings.
Follow George Archos:
About Verano Holdings: Verano is a vertically integrated, multi-state cannabis operator.
Founder and CEO of Cresco Labs
Charles Bachtell serves as Co-Founder and Chief Executive Officer at Cresco Labs, LLC. He served as an Executive Vice President and General Counsel at Guaranteed Rate, Inc. Charles Bachtell served as the head of the legal and loss mitigation departments at Guaranteed Rate. He managed matters concerning legal, regulatory/legislative compliance, credit risk, corporate governance, and acquisitions, among others. Additionally, he is a board member of the Guaranteed Rate Foundation, the company’s nonprofit (501 c3) arm. Charles Bachtell worked with Guaranteed Rate. He obtained his Bachelor of Science degree in business administration with an emphasis in finance from the University of Arizona from 1996 to 2000 and his Juris Doctor from DePaul University College of Law.
Follow Charlie Bachtell:
About Cresco Labs: Cresco Labs is a vertically-integrated multi-state cannabis operator inciting the progressive evolution of the medical cannabis industry.
Chief Executive Officer of UnitedHealth Group
Andrew Hayek has served as our Chief Executive Officer since 2008. Prior to joining SCA, Andrew served as the President of a division of DaVita Healthcare Partners (a renal dialysis and medical group provider), as President and Chief Operating Officer of Alliance Healthcare Services (a diagnostic imaging and radiation therapy provider), and in roles at Kohlberg Kravis Roberts & Co. (a global investment firm) and the Boston Consulting Group (a global management consulting firm). Andrew is a Henry Crown Fellow at the Aspen Institute and serves as Chairman of SCA Medical Missions (a surgical mission program). Andrew also serves as Chief Executive Officer of OptumHealth, one of three segments of Optum and the one that includes SCA. Andrew earned a Bachelor of Arts summa cum laude from Yale University.
Follow Andrew Hayek:
About Firsthand, UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
President & Chief Executive Officer of Abbott
Follow Robert Ford:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
President & CEO of FIGMD
Sanket is a Health IT expert, innovator and entrepreneur. As the head of FIGmd he has pioneered groundbreaking products, processes and services and has established partnerships with some of the country’s largest medical societies. Prior to FIGmd, Sanket led business and technology companies that focused on developing and delivering solutions for the healthcare industry.
Follow Sanket Baralay:
About FIGMD: FIGMD is a U.S.-based provider of healthcare quality measurement and improvement solutions.
Chief Executive Officer of Oak Street Health
Mike Pykosz is the Chief Executive Officer at Oak Street Health.
Follow Mike Pykosz:
About Oak Street Health: Oak Street Health is a network of primary care centers for adults on Medicare.
President and CEO of Aptinyx
Norbert Riedel, Ph.D. was Corporate Vice President and Chief Science and Innovation Officer of Baxter International Inc., a diversified healthcare company from March 2001 until January 2013. Before assuming this role, from 1998 to 2001, Norbert Riedel served as President and General Manager of the recombinant therapeutic proteins business unit and Vice President of Research and Development of Baxter’s bioscience business. Prior to joining Baxter, from 1996 to 1998, he was head of worldwide biotechnology and worldwide core research functions at Hoechst-Marion Roussel, now Sanofi-Aventis, a global pharmaceutical company. Previously, he held a series of scientific management positions at Hoechst-Marion Roussel and Hoechst AG. Norbert Riedel is a member of the Board of Directors of ARIAD Pharmaceuticals, Jazz Pharmaceuticals, the Illinois Biotechnology Industry Organization and also serves on the Advisory Board of Northwestern University’s Kellogg School of Management Center for Biotechnology. Most recently, he was appointed by Illinois Governor Pat Quinn to the Illinois Innovation Council. From 1999 to 2010, Norbert Riedel was a member of the Board of Directors of Oscient Pharmaceuticals Corporation, a biopharmaceutical company, and its predecessor company, Genome Therapeutics Corporation, a genomics company. Norbert Riedel was a member of the Supervisory Board of MediGene AG, a biotechnology company from 2003 to 2013. Norbert Riedel was postdoctoral fellow at Harvard University from 1984 to 1987 and an Assistant Professor and Associate Professor of medicine and biochemistry at Boston University School of Medicine from 1987 to 1991, is an adjunct professor at Boston University School of Medicine, an adjunct professor of Medicine at Northwestern University’s Feinberg School of Medicine and was a visiting professor at Massachusetts Institute of Technology in 1992. In 2009, Norbert Riedel was elected as member of the Austrian Academy of Sciences.Norbert Riedel received his Diploma in biochemistry from the University of Frankfurt in 1981 and his Ph.D. in biochemistry from the University of Frankfort in 1983.
Follow Norbert Riedel:
About Aptinyx, Naurex: Aptinyx Inc. is a biopharmaceutical company.
Founder and CEO of Tempus
Eric Lefkofsky is the founder and CEO at Tempus. He is co-founder of Lightbank, a venture fund investing in disruptive technology businesses. He is also the co-founder and Chairman of Groupon (NASDAQ: GRPN), a global e-commerce marketplace, and an early investor in Uptake Technologies, a leading predictive analytics platform for the world’s largest industries; Mediaocean, a leading provider of integrated media procurement technology; Echo Global Logistics (NASDAQ: ECHO), a technology-enabled transportation and logistics outsourcing firm; and InnerWorkings (NASDAQ: INWK), a global provider of managed print and promotional solutions. He co-chairs the Lefkofsky Family Foundation with his wife Liz to advance high-impact initiatives that enhance lives in the communities served. Lefkofsky serves as a Trustee of Lurie Children’s Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry and World Business Chicago. He is also Chairman of the Board of Trustees of Chicago’s Steppenwolf Theatre Company. Lefkofsky is an adjunct professor at the University of Chicago and author of Accelerated Disruption: Understanding the True Speed of Innovation. He graduated from the University of Michigan and received his Juris Doctor at University of Michigan Law School. For more information, visit lefkofsky.com.
Follow Eric Lefkofsky:
About Groupon, Lightbank, Tempus, The University of Chicago Booth School of Business, Zest Health: Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.
Chief Executive Officer of Medline Industries
Charlie joined Medline in 1986 where he started as a sales representative. Since then he has held various positions within the company including sales management, vice president of marketing and vice president of manufacturing. In 1997, he was named CEO. Prior to joining Medline, Charlie was a sales rep with IBM. He received his B.S. degree in Engineering and his MBA from Cornell University.
Follow Charlie Mills:
About Medline Industries: Medline Industries, Inc., based in Mundelein, Illinois,
Sean P. Nolan
President & Chief Executive Officer of AveXis
Sean P. Nolan is an accomplished executive with over 24 years of pharmaceutical industry experience that includes leadership roles in building and creating significant value for both publicly held and private companies. He has a broad base of business experience in a multi-national pharmaceutical organization, M&A activities in a small, private equity backed company ($900MM) and in a public biotech company ($8.3B).He created, transformed, and optimized businesses through insightful leadership, strong execution skills, and deep business strategy and operational expertise. He is skilled at building compelling company, functional, and team visions and translating those visions into accomplishments.
Follow Sean P. Nolan:
About AveXis, InterMune: AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.
Chairman, President & Chief Executive Officer of Horizon Pharma
Mr. Walbert has served as chairman of our board of directors since 2010 and our president and chief executive officer since June 2008. Mr. Walbert served as president, chief executive officer and director of IDM Pharma, Inc., a public biopharmaceutical company which was acquired by Takeda America Holdings, Inc., or Takeda, in June 2009. Prior to IDM, Mr. Walbert served as executive vice president, commercial operations at NeoPharm, Inc., a public biopharmaceutical company. From 2001 to 2005, Mr. Walbert served as divisional vice president and general manager, immunology, where he led the global development and launch of the multi-indication biologic HUMIRA, which is on track to exceed $10.0 billion in 2013 sales, and divisional vice president, global cardiovascular strategy at Abbott, now AbbVie. From 1998 to 2001, Mr. Walbert served as director, CELEBREX North America and arthritis team leader, Asia Pacific, Latin America and Canada at G.D. Searle & Company. From 1991 to 1998, Mr. Walbert also held sales and marketing roles with increasing responsibility at G.D. Searle, Merck & Co., Inc. and Wyeth. Mr. Walbert received his B.A. in business from Muhlenberg College, in Allentown, Pennsylvania. Mr. Walbert serves on the board of directors of XOMA Ltd. (NASDAQ: XOMA), Raptor Pharmaceutical Corp. (NASDAQ: RPTP), the Biotechnology Industry Organization (BIO), the Illinois Biotechnology Industry Organization (iBIO), ChicagoNEXT, a World Business Chicago (WBC) led council of technology leaders and the Greater Chicago Arthritis Foundation. Mr. Walbert was also recently appointed by Illinois Governor Pat Quinn to the Illinois Innovation Council.
Follow Timothy Walbert:
About Horizon Pharma, Horizon Therapeutics, Viela Bio: Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.
Founder & CEO of HealthJoy
Follow Justin Holland:
About HealthJoy: HealthJoy is a benefits experience platform helping employees make smart healthcare decisions with personalized guidance and AI technology.
CEO of Sterigenics
Michael J. Mulhern serves as the Chief Executive Officer of Sterigenics International Inc. Mulhern served as Chief Executive Officer of American Sanitary Inc. and AmSan LLC, subsidiary of American Sanitary Inc.
Follow Michael Mulhern:
About Sterigenics: Sterigenics is a provider of solutions in sterilization and ionization supply chain management; Providing sterilization services.
Co-Founder and CEO of HealthEngine
Jonathan Weiss is a healthcare entrepreneur with experience in founding and operating various international medical companies. He currently leads HealthEngine, a platform bringing purchasers and providers together in a marketplace for healthcare services. Jonathan has served as co-founder & CEO of several businesses including Nations Healthcare, one of the largest diagnostic and surgery centre companies contracted in the United Kingdom to build, staff and manage specialty hospitals diagnosing and treating 300,000 patients annually. Jonathan was also co-founder and director of Premier Health Partners, operating medical networks in the primary health and specialist physician fields throughout the UK and Europe. Jonathan is a medical doctor and has also earned law, business, and economics/policy qualifications. He is a graduate of the University of Chicago’s Pritzker School of Medicine and Booth School of Business, having completed both an MD and an MBA under Chicago’s dual degree program. He was educated as a lawyer, receiving his BA degree from Oxford University, and additionally holds an MSc in Health Economics and Policy from Stanford University and a BA in Government from Harvard University. In addition to his executive duties, Jonathan often acts as a director and consultant to international companies including Fortune 100 US insurers and medical management firms.
Follow Jonathan Weiss:
About BridgeView Partners, HealthEngine, Said Business School, University of Oxford, University of Oxford: HealthEngine promotes competitive pricing among healthcare services and procedures by comparing pricing models and quality rankings.
CEO of Visibly
Brent Rasmussen is the CEO of Opternative, the first online vision testing platform that delivers a prescription for glasses and contact lenses that can be accessible anywhere at anytime. Brent previously headed up the day-to-day operations of the North American division of CareerBuilder, the global leader in human capital solutions. As an accomplished strategist and industry veteran, Rasmussen drove the innovation, expansion and ongoing revenue growth of CareerBuilder.com, the U.S.’s largest online job site, and CareerBuilder Canada. Rasmussen has served in key roles at CareerBuilder for a decade, helping the company to secure and widen its category lead. In his previous positions as COO and Senior Vice President of Sales, he was charged with leading all sales and customer operations and corporate marketing functions of the company. Under his direction, CareerBuilder developed a suite of cutting-edge products, diversified its sales channels and broadened its distribution network, which had a direct effect on CareerBuilder becoming the industry leader in five short years. Pulling from his years of extensive research and experience, Rasmussen is an employment expert who regularly interviews with national TV and radio, and speaks at various industry forums, to discuss hiring trends and workplace developments. He has appeared on Nightly Business Report, FOX Business Countdown to the Closing Bell, CNN American Morning, BusinessWeek Weekend and National Public Radio among others. In addition to his professional commitments, Rasmussen is dedicated to promoting community involvement. He serves as President of CB Cares, an internal group that supports CareerBuilder’s not-for-profit work including educational mentoring and fund-raising for areas in need. Prior to joining CareerBuilder, Rasmussen served as Manager of Business Services for Xerox Corporation, where he worked for nine years. He holds an MBA from the Northwestern University Kellogg School of Management.
Follow Brent Rasmussen:
About Visibly: Visibly offers an online vision test to get a prescription for glasses and contacts from an ophthalmologist.
Chief Executive Officer of Cheer Guard
Matt has been in EMS for over 13 years holding many roles within the private sector. Matt is currently President of Event Medical Solutions, a Chicago based multi-state onsite medical management company.
Follow Matt Schipper:
About Cheer Guard: Cheer Guard, an innovative communication company connecting first responder to a specific athlete’s medical information during an emergency.
Co-Founder & CEO of ExplORer Surgical
Jennifer Fried is the CEO & Co-Founder of ExplORer Surgical .
Follow Jennifer Fried:
About ExplORer Surgical, Portfolia: ExplORer is an interactive surgical playbook that promotes optimal teamwork in the operating room.
CEO and President of Surefire Medical
Mary Szela is the CEO & President at TriSalus Life Sciences .
Follow Mary Szela:
About Aegerion Pharmaceuticals, Surefire Medical, TriSalus Life Sciences: TriSalus Life Sciences develops novel infusion systems for the interventional radiology market.
Bobby Reddy, Jr.
CEO & Co-Founder of Prenosis
Bobby has led Prenosis from inception, driving company vision, building the team, securing clinical and strategic partnerships, and raising funds. He has over 12 years of experience in the research and development of early screening technologies for debilitating diseases with a deep understanding of clinical issues. For several years, Bobby has worked intimately with a wide variety of clinical and administrative hospital personnel to comprehensively understand how technology can address the most critical issues they face. He received a Ph.D. in electrical engineering from the University of Illinois at Urbana-Champaign, an M.S. in electrical engineering from the University of California, Irvine, and B.S. degrees in computer engineering and electrical engineering from the University of California, Irvine.
Follow Bobby Reddy, Jr.:
About Prenosis: Transforming clinical diagnosis with predictive intelligence.
CEO of MATTER
Steven Collens is CEO of MATTER, Chicago’s new healthcare technology startup center and community hub. He also serves as strategic advisor to Pritzker Group Venture Capital, where he focuses on seed-stage investments. Prior to assuming his current role, Steven was senior vice president at Pritzker Group, the investment firm led by Tony and J.B. Pritzker. In that capacity, he led the team that created 1871, Chicago’s center for digital startups that now houses more than 250 early-stage companies. He previously worked at Abbott in a variety of domestic and international functions, including product management, policy and public affairs. In 2005, Steven helped found ConstantWellness.com to give patients control over their health data and allow healthcare providers to coordinate care of their patients. Prior to Abbott, Steven served as a policy advisor to a U.S. Senator. Steven holds an MBA from Northwestern University’s Kellogg School of Management and a BA from Washington University in St. Louis. He serves on the boards of a number of non-profit organizations, including the Chicagoland Entrepreneurial Center and the Chicago Artists’ Coalition, and is a Leadership Greater Chicago fellow.
Follow Steven Collens:
About MATTER, Pritzker Group Venture Capital: MATTER provides the healthcare industry with technology solutions to improve products and services.
CEO and President of ECRI Institute
Follow Marcus Schabacker:
About ECRI Institute: ECRI Institute is a nonprofit organization authority on the medical practices and products.
Chief Executive Officer of Alcon
David J. Endicott is the CEO of Alcon and leads the Alcon Executive Leadership Team. He joined Alcon in July of 2016 as President, Commercial & Innovation, and Chief Operating Officer. Prior to Alcon, Mr. Endicott was President of Hospira Infusion Systems, a Pfizer company. During his tenure there, he led Hospira’s medical device business through a turnaround, carve-out, and eventual sale. Critical to the turnaround, he advanced the company’s product pipeline, returned its products to market from quality disruptions, and accelerated global growth. Before joining Hospira, Mr. Endicott served as an officer and executive committee member of Allergan where he spent more than 25 years of his career in leadership roles across Europe, Asia, Latin America, as well as the US. He accelerated Allergan’s international growth and successfully built new markets focused on medical specialties in the areas of ophthalmology, plastic surgery, dermatology and aesthetic medicine. Mr. Endicott holds an undergraduate degree in Chemistry from Whitman College, an MBA from the University of Southern California, and is a graduate of the Advanced Management Program at the Harvard Business School. He has also served on the Board of Directors of AdvaMed, Zeltiq (ZLTQ), and Orexigen (OREX).
Follow David Endicott:
About Alcon, Hospira: Alcon specializes in developing and manufacturing innovative medicines and devices to serve the full life cycle of eye care needs.
CEO of Synthonics
Mr. Slepicka has more than twenty years experience in the financial industry, most notably as a director of several public companies as well as a senior consultant/advisor to several start-up initiatives including biotechnology and a pharmaceutical training company. Mr. Slepicka spent 15 years as a Portfolio and Risk Manager for global bank UBS, and was president of the bank’s U.S. subsidiary, UBS Futures Inc. Prior to his senior positions at UBS, Mr. Slepicka was a derivative trader and risk manager for O’Connor and Associates. Mr. Slepicka then worked with a private equity group that invested in a medical device company and has an MBA from the JL Kellogg School of Management, Northwestern University.
Follow Kenneth Slepicka:
About Synthonics: Synthonics is a privately-held specialty pharmaceutical company with a focus on metal coordination chemistry.
CEO of JivanaBiotechnology
Follow Sid Hopps:
About JivanaBiotechnology: Jivana Biotechnology is a preclinical-stage biotechnology company
Founder and CEO of Spine Health
Stephanie Burke is the CEO, Co-Founder, and Editor-in-Chief of Veritas Health. She and her brother, Dr. Peter Ullrich, started Spine-health in 1999 with the vision of providing people with high-quality health information online. To ensure the content was the most accurate and authoritative on the web, the websites were modeled after the review process of Medical Journals, with blind medical review of each peer-reviewed article provided by leading specialists who joined the Medical Advisory Board. Now more than 200 medical professionals write for the sites, and a staff of health editors ensures the content meets our rigorous Editorial Guidelines. Stephanie has overseen Spine-health’s growth into Veritas Health, which now operates four websites and Forums, and is considered a leader in online health content and patient education. She has more than 20 years of health-writing experience and has been a featured speaker on the topic of patient education at the North American Spine Society annual conferences, a contributor for Becker’s Spine Review, and edited Lumbar Herniated Disc: The Essential Guide to Finding Back Pain Relief As Chief Editor, Stephanie ensures the company maintains its focus on editorial excellence, producing the highest quality health content for patients dealing with significant health issues. The content on Veritas Health websites has won more than 155 awards for excellence in health care content: Telly Awards, Digital Health Awards, and eHealthcare Leadership Awards. The peer-reviewed articles are often referenced as a source in leading publications such as The Wall Street Journal, New York Times and The Chicago Tribune. The National Institutes of Health has also often used Spine-health as a source for their medical content. Prior to Veritas Health, Stephanie was a consultant for McKinsey & Company, where she advised healthcare clients on business and online strategies, and performance management.
Follow Stephanie Burke:
About Spine Health: Spine Health is a spine medicine portal that supports the education of patients through a combination of peer-reviewed content and more.
Founder, CEO of TheraTest Laboratories
Marius Teodorescu, MD, PhD has direct experience in manufacture of immunoassays and as a Professor at the University of Illinois (UIC) College of Medicine taught immunology to medical students, graduate students and physicians. Dr. Teodorescu also practiced rheumatology at the UIC College of Medicine for 25 years. He has more than 100 publications of original work, inventions, review articles and books chapters in immunology, rheumatology and related fields. In 1988, he founded TheraTest Laboratories Inc., a leading manufacturer and distributor of immunoassay test kits for rheumatology.
Follow Marius Teodorescu:
About TheraTest Laboratories: TheraTest Laboratories, Inc.™ was founded in 1988 by a group of eminent clinical rheumatologists.
CEO and Co-Founder of Third Eye Health
Follow Dan Herbstman:
About Third Eye Health: The largest post-acute telehealth network reducing unnecessary hospital readmissions at scale.
Founder & CEO of Level Ex
Sam sets the vision and strategy for Level Ex.He has spent his entire career leading teams and companies at the cutting-edge of the video game industry. Before Level Ex, Sam was CEO of the leading independent game publisher in Hollywood, acquired by Playtech (PTEC) in 2016. Under his leadership, the company created award-winning mobile games for tens of millions of players based on popular films, including The Hunger Games and Mission: Impossible. Earlier in his career, Sam led the DirectX Graphics team at Microsoft and was responsible for pushing the visual limits of video games across the industry. His team’s work at Microsoft earned a prestigious Technical Emmy for their contribution to the state-of-the-art in interactive entertainment. Sam established his roots at LucasArts working on leading games for Star Wars films. Mission-driven to unleash the latest visual effects and engagement methodologies from the video game industry onto medicine, Sam has leveraged his game development expertise to pioneer the creation of award-winning medical simulations for over 15 years. These training tools have attracted hundreds of thousands of users and garnered support from top academic hospitals. Sam’s name is featured on several technology patents, popular video game titles, and he has been the recipient of numerous industry awards. He currently sits on major video game and technology advisory boards, including Intel and Microsoft. Sam holds an MS in Computer Science from Stanford University, and a BS in Computer Engineering from the University of Illinois.
Follow Sam Glassenberg:
About Level Ex, Playtech: Level Ex is a developer of professional medical video games designed for physicians to capture the challenges of practicing medicine.
Co-Founder & CEO of TimeDoc Health
Follow William Boeglin:
About TimeDoc Health, TimeDoc Health: TimeDoc helps healthcare organizations manage and coordinate care for their chronic disease patients.
Co-Founder & CEO of Cast21
Ashley S. Moy has won numerous international awards for design and research. Prior to cofounding Cast21, the accomplished engineer and researcher has worked in clinics in the United States and abroad to develop medical devices and pharmaceuticals. In 2013, Ashley led a team to develop a probiotic drug to help reduce the incidence of diet-induced heart disease and went on to win the iGEM World Championship. Prior to cofounding Cast21, Moy also did business development for Fibroblast, a healthcare Saas startup. When she is not working, she loves playing and listening to live music with her friends and aerial spinning.
Follow Ashley Moy:
About Cast21: Cast21 is a developer of medical orthopedic products to create a waterproof and breathable cast for fracture and joint care.
President & CEO of Becker’s Hospital Review
Follow Jessica Cole:
About Becker’s Hospital Review: Becker’s Hospital Review is a monthly publication that offers up-to-date business and legal news related to hospitals.
Chief Executive Officer & Co-Founder of Innoblative Designs
Tyler Wanke is Chief Executive Officer & Co-Founder at Innoblative Designs.
Follow Tyler Wanke:
About EDGe Surgical, Innoblative Designs: Innoblative is a medical device company whose mission is to develop innovative advanced energy medical devices.
Founder & Chief Executive Officer of Lifeline Scientific
Mr. Kravitz is an accomplished entrepreneur and inventor who has served in various senior executive, director and advisory positions throughout his career in life sciences. For over 20 years, his focus has been in the fields of trauma and transplantation medicine, women’s reproductive health, therapeutics adherence and regenerative medicine. He is a co-inventor of several dozen medical technology patents and has been a founder of medical technology companies including Organ Recovery Systems where he served as Chairman and CEO. In 2004, he was named in Fast Company magazine’s “Fast 50” list of global entrepreneurs and innovators. Mr. Kravitz is a co-founder of Lifeline Scientific, Inc. and has served as the Company’s Chief Executive Officer since its inception.
Follow David Kravitz:
About Lifeline Scientific: Lifeline Scientific is a medical technology company, develops products and services for cell, tissue, and organ transplantation.
CEO of Blue Health Intelligence(BHI)
As Chief Executive Officer, Swati Abbott is leading the effort for Blue Health Intelligence (BHI®) to leverage data insights to develop innovative analytics solutions. This strategy includes extending the company’s reach to external audiences, while enhancing BHI’s value to Blue Cross and Blue Shield companies. Prior to joining BHI, Abbott served as President of Elsevier/MEDai, an industry leader in predictive analytics, where she provided leadership and strategic vision to position the company at the forefront of the healthcare industry. Before MEDai, Abbott was Managing Director for the Medical Management Strategic Business Unit at ViPS, where she led strategic solutions development for medical management data warehousing and HEDIS reporting for healthcare payer clients. Abbott was also involved in leading SoftMed Systems, Inc. to create and provide solutions for hospitals and integrated delivery networks in the key areas of medical chart abstraction, quality assurance, utilization management, risk management and regulatory reporting. As a respected industry leader, Abbott is a regular speaker at industry conferences, presenting on topics related to predictive modeling, medical home and healthcare clinical analytics. She is also a contributor and member of the editorial board for Predictive Modeling magazine and has been quoted in notable industry publications regarding the use and future of predictive analytics, the state of healthcare analytics and quality improvement initiatives. In 2010, Frost and Sullivan recognized Abbott as one of the Movers and Shakers in healthcare. Abbott holds a Master of Science in computer science and a Bachelor of Science in physics from Delhi University, India.
Follow Swati Abbott:
About Blue Health Intelligence(BHI): Blue Health Intelligence accesses the industry’s comprehensive, conformed healthcare database of integrated medical and pharmacy claims.
CEO and Founder of Casechek
Matt founded Casechek when he couldn’t find a hospital that was happy with how they managed vendors and vendor inventory. Thanks to loyal customers and their amazing feedback, what started as simple software solution in December of 2014, is now a comprehensive platform and service used by leading institutions and healthcare systems across the country. Prior to starting Casechek, Matt spent most of his career in sales and marketing roles for healthcare startups and medical device companies. He grew up in his favorite city, Toronto, Canada and somehow made his way to Miami University in Oxford, Ohio. While at Miami, Matt played football and graduated with a double major in Manufacturing Engineering and Engineering Management. Not to be outdone by his studious parents, Matt went back to school and earned his MBA from Northwestern University’s Kellogg School of Management. Matt lives in Chicago’s West Loop with his amazing wife Margo, their two over-active children and Jost.
Follow Matt Brandt:
About Casechek: Casechek is a Chicago-based implant supply chain automation company.
President and Chief Executive Officer of Omron Healthcare
Ranndy Kellogg is the newly appointed CEO of Omron Healthcare, responsible for operations across the U.S., Canada and Latin America. With almost 30 years of experience in health and wellness, Ranndy will lead Omron in its mission to free a generation from heart attack and stroke.
Follow Ranndy Kellogg:
About Omron Healthcare: Omron Healthcare creates products for health and wellness, personal fitness, and monitoring blood pressure.
President and Chief Executive Officer of PartsSource inc.
Philip Settimi serves as a President and Chief Executive Officer at PartsSource.
Follow Philip Settimi:
About PartsSource inc.: PartsSource is the leading provider of replacement parts solutions for healthcare.
President & Chief Executive Officer of Knowles Electronics
Jeffrey Niew is president and CEO of Knowles Corporation, the leading global supplier of advanced micro-acoustic solutions, audio processing and specialty components serving mobile consumer electronics, wearables, IoT, medical technology, telecommunications infrastructure, military/space and other industrial end markets. Jeffrey’s leadership, technology insight and operational expertise have strengthened Knowles’ culture of innovation, expanded the company into new markets and extended its product portfolio and global reach. Prior to his appointment as CEO in 2013, Jeffrey was president and CEO of Dover Communication Technologies. During his time as Knowles Electronics’ chief operating officer, Jeffrey was responsible for day-to-day global operations, product research and development and financial performance. During his tenure as vice president and general manager of Knowles Acoustics, the consumer products division, he was responsible for the development and commercialization of the first surface-mounted MEMS microphone, the SiSonic™ Series. This technological advancement remains the industry standard today. Before joining Knowles in 2000, Jeffrey was the business development manager for Littelfuse, Inc., a global electronics manufacturer specializing in the consumer and automotive markets. Jeffrey also held various engineering and marketing positions in the optoelectronics division of Hewlett-Packard. Jeffrey is currently a board member of Advanced Diamond Technologies, Inc. and sits on the University of Illinois – College of Engineering Advisory Board. Jeffrey holds a Bachelor of Science degree in mechanical engineering from the University of Illinois at Chicago.
Follow Jeffrey Niew:
About Knowles Electronics: Knowles Electronics is a Supplier of performance audio, intelligent audio, specialty components in the mobile communications.
President, CEO of HealthCall
Follow Daniel Hayes:
About HealthCall: HealthCall is a company providing cloud-based solutions to enable the communication between healthcare professionals and patients.
Founder & CEO of EveryDose
Andrew Hourani serves as a Founder & CEO at EveryDose.
Follow Andrew Hourani:
About EveryDose: EveryDose is a digital health company committed to improving medication adherence through technology.
CEO of StaffUpMed
Founder of StaffUpMed
Follow Rahul Dhawan:
About StaffUpMed: The Job Board for the Healthcare Industry
Co-Founder and CEO of Orunje
Dr. Athwal is a radiologist who has dedicated the last decade of his life to healthcare. He has published numerous articles pertaining to multiple facets of medicine, and has presented his research at numerous national conferences. During his training, Dr. Athwal decided to pursue a master’s in business administration with an emphasis on healthcare leadership. As he came to better understand the business of healthcare, he found a large disconnect between patients and physicians. Since then, he has played an active role in many healthcare leadership societies and his ultimate goal with Orunje is to reshape the healthcare frontier.
Follow Pardeep Athwal:
About Orunje: Orunje is a location based platform, which connects patients with vetted local area doctors and nurse practitioners.
President and Chief Executive Officer of Urovant Sciences
Follow James Robinson:
About Urovant Sciences: Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Co-Founder and Chief Executive Officer of Ingenza
Follow Sinil Srivastava:
About Ingenza, NanoPsy: Ingenza is an industrial biotechnology company.
CEO and Technical Director of Callibra
Dr. Chris Galassi possesses a depth of experience in intelligent software and knowledge-based systems, particularly in the area of patient documentation. He earned a master’s degree in computer science (artificial intelligence) from the University of Illinois and worked previously as a software engineer for the Department of Defense. Subsequently, he completed a doctorate of medicine from the University of Illinois and training in computation applied to medicine at the University of Illinois and the National Institutes of Health National Library of Medicine, as well as clinical training. Prior to his involvement with Callibra, he started Innovative Projects Lab, Inc., where he led technology consulting efforts for large corporate clients such as the American Hospital Association, Abbott Labs, and Arthur Andersen. He was a founding member of what is now the Illinois Biotechnology Industry Association and served on the board of directors of Chicago’s Biotechnology Association for three years.
Follow Christopher Galassi:
About Callibra: Discharge 1-2-3 provides software and document libraries.
Founder & CEO of MiracleCord
Mark Locascio serves as the Founder and CEO of MiracleCord. Mr. Locascio is a highly accomplished entrepreneur, with more than 30 years’ experience serving in senior executive, director and advisory positions throughout his career. He is an innovator whose leadership, expertise, and acute business acumen have served as the foundation for his many business achievements.
After experiencing the loss of a close family member to Leukemia, Mr. Locascio founded MiracleCord in an effort to help other families facing life-threatening diseases and conditions.
Follow Mark Locascio:
About MiracleCord: MiracleCord is a biotechnology company that provides cord blood and cord tissue banking services to families.
Co-Founder, CEO of DisputeBills.com
Follow Matt Moulakelis:
About DisputeBills.com: Technology and advocacy combined to reduce consumer healthcare costs and debt.
Co-Founder & CEO of Neopenda
Follow Sona Shah:
About Neopenda: Neopenda innovates needs-based medical technologies for high-growth emerging markets.
Philip R. Troyk
President & CEO of Sigenics
Philip Troyk is the President & CEO at Sigenics Inc.
Follow Philip R. Troyk:
About Sigenics: Sigenics was established in December 2000 with one purpose in mind: to provide excellence in silicon
Chief Executive Officer of ProPharma Group
Michael Stomberg is the Chief Executive Officer at ProPharma Group.
Follow Michael Stomberg:
About ProPharma Group: ProPharma Group is the independent, single-source provider of regulatory, compliance, pharmacovigilance, and medical information services.
President & CEO of Preora Healthcare
John Hart currently works as the President and CEO for Preora Healthcare.
Follow John Hart:
About NanoCytomics, Preora Healthcare: Preora Healthcare is a medical device company focused on developing nanocytology technology for the early detection and treatment of cancer.
CEO of Michigan Rural Healthcare Preservation, Inc.
Ethan Lipkind is CEO at Michigan Rural Healthcare Preservation, Inc.
Follow Ethan Lipkind:
About Michigan Rural Healthcare Preservation, Inc.: Michigan Rural Healthcare Preservation, Inc.
J. Todd Phillips
CEO of Parson Partners
Follow J. Todd Phillips:
About Parson Partners: Chicago-based consulting boutique that helps transform organizations and their leaders
Co-Founder and CEO of PhotoniCare
CEO & Co-founder at PhotoniCare. Adjunct Lecturer at University of Illinois at Urbana-Champaign.
Follow Ryan Shelton:
About National Institutes of Health, PhotoniCare, University of Illinois at Urbana-Champaign: PhotoniCare has developed a patented imaging platform technology that provides growth opportunities beyond otology.
CEO & President of EDGe Surgical
Follow Christopher Wilson:
About EDGe Surgical: EDGe Surgical is a medical device company that offers innovative precision measurement solutions for orthopedic surgery.
CEO and Founder of Medical Shipment
Follow Dan Micic:
About Medical Shipment: MEDICAL SHIPMENT LLC is a premium supplier of simulation nursing supplies and equipment.
Founder and CEO of The Healing Clinic
Follow Feliza Castro:
About The Healing Clinic: The Healing Clinic is chicago’s first medical marijuana patient advocacy center.
Caralynn Nowinski Collens
CEO and Co-Founder of Dimension Inx
Caralynn Nowinski Collens is the Co-Founder and CEO of Dimension Inx.
Follow Caralynn Nowinski Collens:
About Dimension Inx: Dimension Inx focuses on creating advanced biomaterials and 3D-printed implants that fundamentally change human disease treatment.
CEO & Co-Founder, SpineCraft of SpineCraft
Wagdy Asaad, MD is the President, CEO & Co-Founder at SpineCraft.
Follow Wagdy Asaad:
About SpineCraft: SpineCraft develops spinal implants designed for revision surgery, deformity correction, degenerative and MIS spine procedures.
Founder , CEO & President of Metrasens
Follow Simon Goodyear:
About Metrasens: Metrasens develops, markets, and installs medical devices that improve safety in hospitals.
CEO of Ardor Medicos India Private Limited (amedicos)
Follow Manoj Kumar:
About Ardor Medicos India Private Limited (amedicos): Ardor Medicos India is an online portal that helps individuals find and review doctors and make appointments.
Lewis A. Mitchell
CEO of Physician Software Systems
Lewis A. Mitchell is the CEO at Physician Software Systems.
Follow Lewis A. Mitchell:
About Physician Software Systems: Physician Software Systems commercializes a method of managing the anemia for hemodialysis patients.